Ropharma Brasov
I · AI Analysis
The brief
Ropharma operates pharmacy chains selling prescription drugs, over-the-counter medications, supplements, and medical devices across Romania [Yahoo Finance]. The company also runs specialized medical centers offering oncology, bariatric and robotic surgery, renal transplants, and cardiovascular treatment [Yahoo Finance]. Additionally, Ropharma manufactures its own pharmaceutical products, food supplements, and dermocosmetics [Yahoo Finance].
Ropharma is a Romanian pharmaceutical retail and healthcare company operating a chain of pharmacies and medical facilities, including specialized oncology and surgical centers [Yahoo Finance]. The company reported a dramatic 627% surge in net profit to 5.7 million lei in the first half of 2026 [informat.ro], though trailing-twelve-month margins remain razor-thin at 0.2% net [Yahoo Finance]. With 1,758 employees and RON 1.6 billion in revenue, Ropharma is expanding rapidly but carries elevated financial risk [Yahoo Finance].
Strong revenue growth but wafer-thin profitability with elevated debt burden [Yahoo Finance].
Sentinellis health
Significant risks
3.7/10
7.5+ strong · 4.5–7.5 moderate · under 4.5 weak
Profitability
Returns on capital
Growth & momentum
Balance sheet
Cash generation
Value creation
Sentinellis calculation from the published statements — not a score reported by any data source. Each category is scored on the checks that had data; missing inputs are excluded rather than counted as failures.
Market capitalisation
RON 112.5M
Revenue (TTM)
RON 1.6B
II · Recent news
What moved
3 stories · ranked by relevance
- company2026-08-31
Ropharma reports a net profit of 5.7 million lei, an increase of 627% compared to last year. - Informat.ro
informat.ro
- company2026-08-31
Ropharma raportează un profit net de 5,7 mil. lei, în creștere cu 627% față de anul trecut - Informat.ro
informat.ro
- company2026-08-31
Grupul farmaceutic Ropharma şi-a majorat profitul de şapte ori în prima jumătate a anului, la 5,7 mil. le - Ziarul Financiar
Ziarul Financiar
Premium · Free with any account
Operating margin of 1.2% and net margin of 0.2% mean profitability is extremely fragile — a small increase in input costs, wage pressure, or competitive discounting could erase earnings entirely [Yahoo Finance].
Risks
5
Opportunities
5
Red flags
3
Leadership
3
12 more findings in the full report — free with any account.
Unlock the full Ropharma Brasov analysis
Create a free account to access the complete AI-generated report with inline citations.
- 5 risks, 5 opportunities and 3 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare — or comparable health
Want this for your watchlist?